Post-traumatic stress disorder and risky opioid use among persons living with HIV and chronic pain

• Type of Material: Article
• Authors: Elenore Bhatraju, Harborview Medical Center and University of Washington Seattle; Jane M Liebschutz, University of Pittsburgh; Sara Lodi, Boston University; Leah S Forman, Boston University; Marlene C Lira, Boston University; Theresa W Kim, Boston University; Jonathan Colasanti, Emory University; Carlos del Rio, Emory University; Jeffrey H Samet, Boston University; Judith I Tsui, Harborview Medical Center and University of Washington Seattle
• Language: English
• Date: 2021-02-04
• Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
• Publication Version: Author Accepted Manuscript (After Peer Review)
• Copyright Statement: Rights managed by Taylor & Francis
• License: Creative Commons Attribution-NonCommercial 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.1080/09540121.2021.1876838
• Title of Journal or Parent Work: AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV
• Start Page: 1
• End Page: 8
• Grant/Funding Information: This study was supported by the National Institute on Drug Abuse (R01DA037768). Dr. Samet and Dr Lodi received support from the Providence/Boston Center for AIDS Research (CFAR - P30AI042853). Dr Del Rio receives support from the center for AIDS Research at Emory University (CFAR- P30AI050409) Dr. Tsui reports additional support from P30AI027757. Center for AIDS Research, University of Washington. Harvard University Center for AIDS Research
• Keywords: Psychology, Multidisciplinary; Biomedical Social Sciences; opioid; Social Sciences; Psychology; Health Care Sciences & Services; pain; Life Sciences & Biomedicine; HIV; Social Sciences, Biomedical; Respiratory System; PTSD; Public, Environmental & Occupational Health; Science & Technology; Health Policy & Services

Abstract

Persons with HIV (PWH) experience chronic pain and Post-Traumatic Stress Disorder (PTSD) at higher rates than the general population, and more often receive opioid medications to treat chronic pain. A known association exists between PTSD and substance use disorders, but less is known about the relationship between PTSD and risky opioid use among PWH taking prescribed opioid medications. In this observational study of PWH on long-term opioid medications for pain we examined associations between PTSD symptom severity based on the Post Traumatic Stress Disorder Checklist for DSM-5 (PCL-5, response range 0-80) and the following outcomes: 1) risk for opioid misuse (COMM score ≥13); 2) risky alcohol use (AUDIT score ≥8); 3) concurrent benzodiazepine prescription; and 4) morphine equivalent dose. Among 166 patients, 38 (23%) had a PCL-5 score over 38, indicating high PTSD symptom burden. Higher PCL-5 score (per 10 point difference) was associated with increased odds of opioid misuse (aOR 1.55; 95%CI: 1.31-1.83) and risky drinking (aOR: 1.28;1.07-1.52). No significant association was observed between PCL-5 score and benzodiazepine prescriptions or morphine equivalent dose. These findings suggest that when addressing alcohol and opioid use in PWH on long term opioid therapy, attention to PTSD symptoms is especially important given the higher risk for risky alcohol and opioid use among patients with this common comorbid condition.